| http://www.w3.org/ns/prov#value | - Argos is actively developing immunotherapies or indications such as cancer, infectious diseases, autoimmune disorders, and transplantation using its Arcelis technology, which trains the immune system to recognize and attack the disease. ???The licensing agreement with Therakos will enable accelerated development of an asset outside our primary focus, while providing Argos with nondilutive financia
|
